The Effect of PinnoThin on Satiety and Food Intake
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Dec 16, 2009
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • age over 18 and under 45
- • women
- • BMI over 23 and under 30
- • breakfast eaters
- Exclusion Criteria:
- • men
- • age under 18 and over 45
- • BMI under 23 and over 30
- • use of medication
- • pregnant and breastfeeding
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, Limburg, Netherlands
Patients applied
Trial Officials
Klaas R Westerterp, Prof
Principal Investigator
NUTRIM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials